Thyrocare Technologies Ltd (THYROCARE) — Voting Results | 28 September 2026

28 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Thyrocare proposes two special resolutions for shareholder approval via postal ballot.

💡 Investor Takeaway

Shareholders must vote on key related-party transactions affecting company structure.

Thyrocare Technologies proposed two special resolutions via postal ballot: approval to purchase land from its subsidiary Nueclear Healthcare and to divest its entire stake in the subsidiary. The board recommends voting FOR both resolutions. E-voting opens September 30, 2026, and closes October 29, 2026, with results declared by November 2, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — THYROCARE ✨ Ask AI About This

About Thyrocare Technologies Ltd (THYROCARE)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹8,700.77 CrP/E: 49.5ROE: 34.4%ROCE: 45.6%Div Yield: 1.28%

View full THYROCARE stock details →

📡 Get AI alerts when THYROCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THYROCARE — Free

💡 Ask AI about this filing

"What is the purchase price and valuation of the land from Nueclear Healthcare?""What is the expected timeline and conditions for completing the divestment?""How will the divestment impact Thyrocare's financials and strategic direction?"

Ask AI Free →

📊 More THYROCARE filings

Announcement — 24 September 2026Thyrocare Technologies has closed its insider trading window effective October 1, 2026, until 48 hou...
🟡 Board Meeting — 24 September 2026Thyrocare Technologies approved the grant of 1,92,000 employee stock options at a Rs. 10 exercise pr...
🟡 Board Meeting — 21 September 2026Thyrocare Technologies announced the board approved the sale of its entire 100% stake in radiology s...
🔴 Corporate Action — 21 September 2026Thyrocare Technologies announced on September 21, 2026, that its board approved the sale of its enti...
🟡 Board Meeting — 21 September 2026Thyrocare Technologies announced on September 21, 2026, that its board approved the sale of its enti...

See all THYROCARE filings →

🔥 Also filed on 28 September 2026

JSLJindal Stainless LtdCorporate Action GODREJPROPGodrej Properties LtdAnnouncement MANINFRAMan Infraconstruction LtdAnnouncement KPILKalpataru Projects International LtdAnnouncement SUNPHARMASun Pharmaceutical Industries LtdAnnouncement JUBLPHARMAJubilant Pharmova LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THYROCARE files new disclosures

Track THYROCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.